MedTrace Logo

Immersive Virtual Reality for Older Adults in Long-Term Care Settings

NCT07658287 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-06-18

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if an immersive virtual reality mindfulness meditation program is feasible and acceptable for older adults living in long-term care settings in Quebec who have mild to moderate neurocognitive disorder. It will also learn about the safety and potential effects of the program on well-being.

The main questions it aims to answer are:

* Is the virtual reality mindfulness meditation program feasible and acceptable for residents and staff in long-term care settings?
* Does the adapted version of the program show potential benefits for well-being, including depression, anxiety, quality of life, mindfulness, pain, and loneliness?
* What practical challenges, user experiences, and side effects, such as cybersickness, occur during the program?

Researchers will compare the original Toujours Dimanche virtual reality mindfulness meditation program, an adapted version of Toujours Dimanche designed for older adults with mild to moderate neurocognitive disorder, and standard care alone to see if the adapted program is feasible, acceptable, and potentially helpful.

Participants will:

* Take part in up to 8 virtual reality mindfulness meditation sessions over 4 weeks, if assigned to a virtual reality group
* Complete questionnaires before and after the 4-week study period
* Share feedback about their experience, when possible
* Be observed by staff or research team members to document feasibility, acceptability, user experience, and safety

Conditions

Interventions

BEHAVIORAL

Guided Mindfulness Meditation

Mindfulness Meditation for Cognitive Impairment

DEVICE

Adapted Virtual Reality Mindfulness Meditation Program

Immersive Virtual Reality Mindfulness Meditation

OTHER

Usual Care

Standard Care

Sponsors & Collaborators

  • McGill University

    collaborator OTHER

  • Université de Sherbrooke

    collaborator OTHER

  • Laval University

    lead OTHER

Principal Investigators

  • Maude Laberge, PhD · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2027-06-15
Completion
2027-06-15

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07658287 on ClinicalTrials.gov